Description: DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.
Home Page: diasoringroup.com/en
Via Crescentino
Saluggia,
VC
13040
Italy
Phone:
39 01 614871
Officers
| Name | Title |
|---|---|
| Mr. Carlo Rosa | CEO, GM & Executive Director |
| Dr. Chen Menachem Even | Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director |
| Mr. Piergiorgio Pedron | Senior Corporate VP, CFO & Corporate Accounting Documents Officer |
| Mr. Fabrizio Piercarlo Bonelli | Corporate VP & Chief Technology Officer |
| Dr. Riccardo Fava | Corporate Vice President of Communication, ESG & Investor Relations |
| Mr. Ulisse Spada | Corporate VP, Head of the Legal Department, Secretary & General Counsel |
| Ms. Amelia Parente | Senior Corporate Vice President of Human Resources |
| Mr. Angelo Rago | President of Luminex Corporation |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 22.3714 |
|---|---|
| Trailing PE: | 30.2925 |
| Price-to-Book MRQ: | 3.4152 |
| Price-to-Sales TTM: | 4.9648 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3184 |